参考文献/References:
[1] Zhao Y, Li H, Men LL, et al. Effects of selenoprotein S on oxidative injury in human endothelial cells[J].J Transl Med,2013,11:287. DOI: 10.1186/1479-5876-11-287.
[2] Speckmann B, Gerloff K, Simms L, et al. Selenoprotein S is a marker but not a regulator of endoplasmic reticulum stress in intestinal epithelial cells[J].Free Radic Biol Med,2014,67:265-277. DOI: 10.1016/j.freeradbiomed.2013.11.001.
[3] Ye Y, Fu F, Li X, et al. Selenoprotein S is highly expressed in the blood vessels and prevents vascular smooth muscle cells from apoptosis[J].J Cell Biochem,2016,117(1):106-117. DOI: 10.1002/jcb.25254.
[4] Gao Y, Pagnon J, Feng HC, et al. Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells[J].Biochem Biophys Res Commun,2007,356(3):636-641.
[5] Walder K, Kantham L, McMillan JS,et al. Tanis: a link between type 2 diabetes and inflammation [J]Diabetes,2002,51(6):1859-1866.
[6] Gao Y, Feng HC, Walder K,et al. Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress-SelS is a novel glucose-regulated protein[J].FEBS Lett, 2004,563(1-3):185-190.
[7] Gao Y, Walder K, Sunderland T, et al. Elevation in Tanis expression alters glucose metabolism and insulin sensitivity in H4IIE cells[J].Diabetes,2003,52(4):929-934.
[8] Du JL, Liu JF, Men LL,et al. Effects of five-year intensive multifactorial intervention on the serum amyloid A and macroangiopathy in patients with short-duration type 2 diabetes mellitus[J].Chin Med J(Engl), 2009,122(21):2560-2566.
[9] Marzi C, Huth C, Herder C, et al. Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study[J].Diabetes Care,2013,36(5):1321-1326. DOI: 10.2337/dc12-1514.
[10] Zhang N, Jing W, Cheng J,et al. Molecular characterization and NF-κB-regulated transcription of selenoprotein S from the Bama mini-pig[J].Mol Biol Rep,2011,38(7):4281-4286. DOI: 10.1007/s11033-010-0551-y.
[11] Karlsson HK, Tsuchida H, Lake S,et al. Relationship between serum amyloid A level and Tanis/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects[J].Diabetes,2004,53(6):1424-1428.
[12] Du JL, Sun CK, Lü B,et al. Association of SelS mRNA expression in omental adipose tissue with Homa-IR and serum amyloid A in patients with type 2 diabetes mellitus[J].Chin Med J(Engl),2008,121(13):1165-1168.
[13] Christensen LC, Jensen NW, Vala A, et al. The human selenoprotein VCP-interacting membrane protein(VIMP)is non-globular and harbors a reductase function in an intrinsically disordered region[J].J Biol Chem,2012,287(31):26388-26399. DOI: 10.1074/jbc.M112.346775.
[14] Liu J, Li F, Rozovsky S. The intrinsically disordered membrane protein selenoprotein S is a reductase in vitro[J].Biochemistry,2013,52(18):3051-3061. DOI: 10.1021/bi4001358.
[15] Chistiakov DA, Sobenin IA, Orekhov AN,et al. Role of endoplasmic reticulum stress in atherosclerosis and diabetic macrovascular complications[J].Biomed Res Int,2014,2014:610140. DOI: 10.1155/2014/610140.
[16] Fradejas N, Serrano-Pérez Mdel C, Tranque P,et al. Selenoprotein S expression in reactive astrocytes following brain injury[J].Glia,2011,59(6):959-972. DOI: 10.1002/glia.21168.
[17] Lee JH, Park KJ, Jang JK,et al. Selenoprotein S-dependent selenoprotein K binding to p97(VCP)protein is essential for endoplasmic reticulum-associated degradation[J].J Biol Chem,2015,290(50):29941-29952. DOI: 10.1074/jbc.M115.680215.
[18] Tousoulis D, Simopoulou C, Papageorgiou N, et al. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches[J].Pharmacol Ther,2014,144(3):253-267. DOI: 10.1016/j.pharmthera.2014.06.003.
[19] Rotllan N, Wanschel AC, Fernández-Hernando A, et al. Genetic evidence supports a major role for akt1 in VSMCs during atherogenesis[J].Circ Res,2015,116(11):1744-1752. DOI: 10.1161/CIRCRESAHA.116.305895.
[20] Curran JE, Jowett JB, Elliott KS, et al. Genetic variation in selenoprotein S influences inflammatory response[J].Nat Genet,2005,37(11):1234-1241.
[21] Martínez A, Santiago JL, Varadé J, et al. Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases[J].BMC Genomics,2008,9:329. DOI: 10.1186/1471-2164-9-329.
[22] Hyrenbach S, Pezzini A, del Zotto E, et al. No association of the -105 promoter polymorphism of the selenoprotein S encoding gene SEPS1 with cerebrovascular disease[J].Eur J Neurol,2007,14(10):1173-1175.
[23] Alanne M, Kristiansson K, Auro K,et al. Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts[J].Hum Genet,2007,122(3-4):355-365.
[24] Li XX, Guan HJ, Liu JP, et al. Association of selenoprotein S gene polymorphism with ischemic stroke in a Chinese case-control study[J].Blood Coagul Fibrinolysis,2015,26(2):131-135. DOI: 10.1097/MBC.0000000000000202.
[25] Cox AJ, Lehtinen AB, Xu J,et al. Polymorphisms in the Selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study[J].Acta Diabetol,2013,50(3):391-399. DOI: 10.1007/s00592-012-0440-z.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(06):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(06):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(06):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(06):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(06):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(06):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(06):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(06):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]